BSE filing, NSE: AKUMS. Summary written from the filing by ALFA Finder's alert engine.
Akums Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹731.70
- Market cap
- ₹11,517 Cr
- Revenue (annual)
- ₹4,359 Cr
- Net profit (annual)
- ₹255.2 Cr
- P/E (TTM)
- 39.5×Sector 45.9×
- Promoter holding
- 75.26%+0.00% QoQ
- FII holding
- 4.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Akums Drugs & Pharmaceuticals Ltd
All →Akums Drugs & Pharmaceuticals Legal & Regulatory
Akums Drugs and Pharmaceuticals received a ₹52.75 Crore NPPA demand notice. The company claims no liability, citing an indemnity agreement with its marketer.
- Value
- ₹52.75 Cr
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing notes the removal of two entities from the promoter group.
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals received an ESG rating of 65 for FY2025-26 from NSE Sustainability Ratings & Analytics Limited. The rating was assigned voluntarily based on publicly available information.
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals Limited has cancelled its participation in the Antique Healthcare Investor Conference scheduled for August 25, 2026, due to unavoidable medical reasons.
Akums Drugs & Pharmaceuticals Earnings Call Transcript: Key Takeaways
Akums reported strong Q1FY27 performance with 13.9% revenue growth and 56.1% PAT increase. Results were driven by a robust 18.6% growth in the CDMO segment and improved API pricing.
Akums Drugs & Pharmaceuticals Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2025, in compliance with SEBI LODR regulations.
Other board meeting date announcements
All →Purple United Sales Board Meeting Date
Purple United Sales will hold a board meeting on 6 November 2026 to approve half-yearly unaudited results and consider fund raising. The fund raise is through debt issue, and the trading window is closed until 8 November 2026.
Capital India Finance Board Meeting Date
Capital India Finance will hold a board meeting on 6 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after results are declared.
Laxmi Goldorna House Board Meeting Date
Laxmi Goldorna House Limited intimated a board meeting on 06 Nov 2026 to consider unaudited quarterly results for the period ended September 2026. The trading window is closed from 01 Oct 2026 until 48 hours after results.
Atma Industries Board Meeting Date
Atma Industries gave prior intimation of its 04 November 2026 board meeting to consider unaudited results for the quarter and half year ended 30 September 2026. The filing also notes the trading window closes from 01 October 2026.
Diana Tea Company Board Meeting Date
Diana Tea Company will hold a board meeting on 5 November 2026 to consider unaudited quarterly and half-yearly results for September 2026. The trading window stays closed from 1 October 2026 until 48 hours after the results are declared.
Cospower Engineering Board Meeting Date
CosPower Engineering will hold a board meeting on 4 November 2026 to consider half-year standalone results. The notice is advance intimation; agenda items are only proposed.